News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Harmony Gold Mining Co Ltd (HMY) shares recently gained 4.6% and are currently trading at $16.47, which is 3.9% below its GF Value™ of $17.13, indicating it is undervalued. The company holds a strong GF Score™ of 88/100 due to robust fundamentals, particularly in …
Sharemaestro market context Price above Trend Line 52 weeks +44.2% · Next-week setup positive 59.3%This page provides a comprehensive overview of HARMONY GOLD MINING CO LTD (HGMCF) SEC filings, including 10-K, 10-Q, and 8-K forms, enhanced with AI-generated summaries, sentiment, and impact scores. Recent filings detail Harmony Gold's 2025 Form 20-F availability, a fatal incident at the Mponeng …
Sharemaestro market context Price above Trend Line 52 weeks +12.3% · Next-week setup positive 58.4%Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Harmony Biosciences Holdings has delivered a 30.8% total return over the past 5 years, yet its current valuation checks on Simply Wall St …
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Event driven interest around Harmony Biosciences Holdings stock Fresh attention is turning to Harmony Biosciences Holdings (HRMY) after research firm Zacks assigned the …
Harmonic Inc (HLIT) currently holds a financial score of 7.32, ranking 20th out of 54 in its industry, indicating stable financial health with average operating efficiency. The company's latest quarterly revenue decreased by 8.59% year-over-year to $121.69 million, and its net profit saw a …
Mizuho has maintained an "Outperform" rating for Harmony Biosciences Holdings (HRMY) and increased its price target to $51.00, reflecting optimism for the biotechnology company. HRMY is currently valued at $34.76, indicating a 26.5% undervaluation according to GuruFocus's GF Value™ of $47.30, and holds a …
Mizuho has increased its price target for Harmony Biosciences Holdings (HRMY) to $51 from $50, while reiterating an Outperform rating. This adjustment suggests a continued positive outlook on the company's stock performance.
Harmony Gold Mining Company Ltd (HMY) is a mining company with operations in South Africa, Papua New Guinea, and Australia, focusing on gold, uranium, and copper. The company's fundamentals are considered healthy with significant growth potential, high profit growth, and a strong dividend, though …
Harmony Gold Mining Co Ltd (HMY) experienced a 4.0% rally, with its shares currently trading at $16.15. According to GuruFocus' GF Value™, the stock is estimated to be 5.7% undervalued at $17.12, and its GF Score™ of 88/100 suggests strong overall performance, particularly in …
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Harmony Biosciences Holdings, Inc. (HRMY) or Acadia Pharmaceuticals (ACAD). But which of these two stocks presents investors with the better value opportunity right now? Let's take a …
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Considering these trends, …
Harmonic, Inc. (HLIT) had approximately 538 employees worldwide as of March 2026, marking a 5.4% decline from 2023. The company, headquartered in San Jose, California, saw its total headcount fluctuate but recover to 538 by 2026, with a significant concentration of its workforce in …
Harmony Biosciences Holdings Inc (HRMY) has a current valuation score of 8.09, placing it 108th out of 155 in the Pharmaceuticals industry. The company's P/E ratio stands at 14.19, which is significantly below its recent high and above its recent low. Key valuation metrics …
This article provides a technical analysis of Harmonic Inc (HLIT), focusing on its price momentum, support and resistance levels, and various technical indicators. It notes a current price momentum score of 5.24 and suggests the stock is trading within a range suitable for swing …
This article provides a detailed analysis of Harmonic Inc. (HLIT), including its current stock price, market trends, financial indicators, and analyst ratings. Despite a recent weak stock performance, the company shows strong fundamentals with significant growth potential, and its valuation is considered fairly valued …
This Zacks.com article highlights five undervalued price-to-book stocks: Harmony Biosciences, Invesco, General Motors, Hewlett Packard Enterprise, and Quanex Building Products. It explains the P/B ratio as a tool for identifying undervalued stocks, defining book value and its calculation, and discusses the importance of comparing …
Argus has lowered its target price for Harmony Biosciences Holdings Inc (HRMY) to $38.00. The company is a commercial-stage pharmaceutical firm specializing in therapies for rare neurological diseases. The current price of HRMY stock is $35.86.
Harmony Biosciences Holdings Inc (HRMY) shows strong fundamentals, high growth potential, and is considered fairly valued within the Pharmaceuticals industry. The company's revenue has grown significantly, and it boasts high profit growth and institutional confidence. Analysts have rated the stock as "Buy" with an …
The article provides an overview of market sentiment for Harmonic (HLIT), including analyst consensus, short interest, and recent analyst actions. It shows that the analyst consensus is "Buy" with an average price target of $15, indicating a potential upside for the stock. The short …
BlackRock, Inc. has filed an amended Schedule 13G/A revealing a beneficial ownership of 6,525,663 shares of Harmony Biosciences Holdings, Inc. common stock, which represents an 11.3% stake in the company. BlackRock exercises sole voting power over 6,445,523 shares and sole dispositive power over all …
Harmony Biosciences Holdings, Inc. (HRMY) is expected to report a year-over-year increase in earnings and revenues for the quarter ended June 2026, with Wall Street anticipating $0.97 EPS and $252.54 million in revenue. The company holds a Zacks Rank of #1 (Strong Buy) and …
Harmony Gold Mining Company Limited has successfully secured new syndicated, multi-tranche, multi-currency loan facilities totaling US$500 million, A$500 million, and R7 billion. These facilities are significantly oversubscribed, reflecting strong lender confidence, and will reduce funding costs, extend the debt maturity profile, and strengthen liquidity. …
Sharemaestro market context Price above Trend Line 52 weeks +44.2% · Next-week setup positive 59.3%This article details precision trading strategies for Harmonic Inc. (HLIT) based on AI-generated signals, highlighting a significant risk-reward setup targeting a 19.5% gain versus 0.3% risk. It outlines distinct position, momentum, and risk-hedging strategies with specific entry, target, and stop-loss zones. The analysis indicates …
Harmonic (NASDAQ: HLIT) announced it will release its second quarter 2026 financial results on Wednesday, August 12, 2026, after market close. The company will host a live webcast at 2:00 p.m. PT on the same day to discuss results, which aligns with financial reporting …
Harmonic (NASDAQ: HLIT) announced it will release its second quarter 2026 financial results after market close on Wednesday, August 12, 2026. This will be followed by a live webcast and earnings conference call at 2:00 p.m. PT. The timing accommodates financial reporting related to …
This article provides the quarterly and annual income statements for Harmony Biosciences Holdings Inc (HRMY), offering detailed financial data such as total revenue, operating expenses, net income, and earnings per share. It also includes key financial metrics and answers frequently asked questions about analyzing …
Neurocrine Biosciences NBIX is scheduled to report second-quarter 2026 results on July 30, after market close. We expect investors to focus on the sales performance of NBIX's marketed products and other pipeline updates when the company reports quarterly results. The Zacks Consensus Estimate for …
This article provides a detailed balance sheet for Harmonic Inc (HLIT), covering quarterly and annual financial data from FY2012Q1 to FY2026Q1. It includes metrics like cash and cash equivalents, receivables, inventory, total assets, various liabilities, and shareholders' equity, allowing users to analyze the company's …
This article provides key financial data for Harmony Biosciences Holdings Inc (HRMY), including its market capitalization of $2.08 billion and a P/E TTM of 14.25. It shows the company's revenue breakdown by region, with $868.45 million from the United States, but notes that detailed …
This article provides details on Harmonic Inc's institutional confidence score, shareholding proportion, and major institutional shareholders. Harmonic Inc (HLIT) has an institutional shareholding score of 10.00, ranking 1st in its industry, with institutional shareholding at 103.19%, an increase of 12.85% quarter-over-quarter. First Eagle Investment …
Search by ticker symbol or company name and select a result to open its chart.